Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor

American Journal of Medical Genetics, Part A

Volumn 149, Issue 12, 2009, Pages 2855-2859

  Lafay Cousin, Lucie ^a   Payne, Eric ^a   Strother, Douglas ^a   Chernos, Judy ^a,b   Chan, Michael ^a   Bernier, Francois P ^b  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Atypical teratoid rhabdoid tumors; Distal 22q11 deletion syndrome; Goldenhar syndrome

Indexed keywords

TAMOXIFEN;

ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHROMOSOME 22Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GOLDENHAR SYNDROME; HUMAN; INFANT; INI1 GENE; INTRACRANIAL TUMOR; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRIORITY JOURNAL; RHABDOID TUMOR; SMARCB1 GENE; TERATOMA; TUMOR SUPPRESSOR GENE;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; GOLDENHAR SYNDROME; HUMANS; INFANT; INFANT, NEWBORN; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PREGNANCY; RHABDOID TUMOR; TERATOMA;

EID: 71949127354     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33119     Document Type: Article

References (27)

1. Albrecht P, Ansperger-Rescher B, Sch€uler A, Zeschnigk M, Gallie B, Lohmann DR. 2005. Spectrum of gross deletions and insertions in the RB1 gene in patients with retinoblastoma and association with phenotypic expression. Hum Mutat 26:437-445. (Pubitemid 41572450)
2. Ben-Shachar S,OuZ, Shaw CA, Belmont JW, Patel MS,HummelM, Amato S, Tartaglia N, Berg J, Sutton VR, Lalani SR, Chinault AC, Cheung SW, Lupski JR, Patel A. 2008. 22q11.2 distal deletion: A recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome. Am J Hum Genet 82:214-221. (Pubitemid 351726089)
3. Biegel JA. 2006. Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg Focus 20:E11.
4. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. 1999. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74-79. (Pubitemid 29062960)
5. Biegel JA, Fogelgren B, Wainwright LM, Zhou JY, Bevan H, Rorke LB. 2000. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Genes Chromosomes Cancer 28:31-37. (Pubitemid 30176760)
6. Bourdeaut F, Fréneaux P, Thuille B, Lellouch-Tubiana A, Nicolas A, Couturier J, Pierron G, Sainte-Rose C, Bergeron C, Bouvier R, Rialland X, Laurence V, Michon J, Sastre-Garau X, Delattre O. 2007. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol 211:323-330. (Pubitemid 46172708)
7. Engiz O, Balci S, Unsal M, Ozer S, Oguz KK, Aktas D. 2007. 31 cases with oculoauriculovertebral dysplasia (Goldenhar syndrome): Clinical, neuroradiologic, audiologic and cytogenetic findings. Genet Couns 18: 277-288. (Pubitemid 350033528)
8. Goldenhar M. 1952. Association malformative de l'oeil et de l'Oreille, en particulier le syndrome dermoide epibulbaire-appendices auriculaires fistula auris congenital et ses associations avec la dysostose mandibulofaciale. J Genet Hum 1:243-282.
9. Gorlin RJ, Cohen MM, Jr., Hennekam RCM. 2001. Syndromes of the head and neck, 4th edition. New York: Oxford University Press. pp 790-798.
10. Herman GE, Greenberg F, Ledbetter DH. 1988. Multiple congenital anomaly/mental retardation (MCA/MR) syndrome with Goldenhar complex due to a terminal del(22q). Am J Med Genet 29:909-915.
11. Jackson EM, Shaikh TH, Gururangan S, Jones MC, Malkin D, Nikkel SM, Zuppan CW, Wainwright LM, Zhang F, Biegel JA. 2007. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Hum Genet 122:117-127. (Pubitemid 47241777)
12. Janson K, Nedzi LA, David O, Schorin M, Walsh JW, Bhattacharjee M, Pridjian G, Tan L, Judkins AR, Biegel JA. 2006. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation. Pediatr Blood Cancer 47:279-284. (Pubitemid 44148044)
13. Judkins AR. 2007. Immunohistochemistry of INI1 expression: A new tool for old challenges in CNS and soft tissue pathology. Adv Anat Pathol 14:335-339.
14. Kusafuka T, Miao J, Yoneda A, Kuroda S, Fukuzawa M. 2004. Novel germline deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor. Genes Chromosomes Cancer 40:133-139. (Pubitemid 38579881)
15. Rauch A, Zink S, Zweier C, Thiel CT,Koch A, Rauch R, Lascorz J,Hüffmeier U, Weyand M, Singer H, Hofbeck M. 2005. Systematic assessment of atypical deletions reveals genotype-phenotype correlation in 22q11.2. J Med Genet 42:871-876. (Pubitemid 41598197)
16. Roberts CW, Biegel JA. 2009. The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther 8:412-416.
17. Rollnick BR, Kaye CI, Nagatoshi K, Hauck W, Martin AO. 1987. Oculoauriculovertebral dysplasia and variants: Phenotypic characteristics of 294 patients. Am J Med Genet 26:361-375. (Pubitemid 17225979)
18. Saitta SC, McGrath JM, Mensch H, Shaikh TH, Zackai EH, Emanuel BS. 1999. A 22q11.2 deletion that excludes UFD1L and CDC45L in a patient with conotruncal and craniofacial defects.AmJ HumGenet 65:562-566.
19. Shaikh TH, Kurahashi H, Saitta SC, O'Hare AM, Hu P, Roe BA, Driscoll DA, McDonald-McGinn DM,Zackai EH, Budarf ML, Emanuel BS. 2000. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: Genomic organization and deletion endpoint analysis. Hum Mol Genet 9:489-501. (Pubitemid 30154007)
20. Shaikh TH, O'Connor RJ, Pierpont ME, McGrath J, Hacker AM, Nimmakayalu M, Geiger E, Emanuel BS, Saitta SC. 2007. Low copy repeats mediate distal chromosome 22q11.2 deletions: Sequence analysis predicts breakpoint mechanisms. Genome Res 17:482-491. (Pubitemid 46556452)
21. Stankiewicz P, Lupski JR. 2002. Genome architecture, rearrangements and genomic disorders. Trends Genet 18:74-82. (Pubitemid 34127806)
22. Strömland K, Miller M, Sjögreen L, Johansson M, Joelsson BM, Billstedt E, Gillberg C, Danielsson S, Jacobsson C, Andersson-Norinder J, Granström G. 2007. Oculo-auriculo-vertebral spectrum: Associated anomalies, functional deficits and possible developmental risk factors. Am J Med Genet Part A 143A:1317-1325. (Pubitemid 46870098)
23. Taylor M, Dehainault C, Desjardins L, Doz F, Levy C, Sastre X, Couturier J, Stoppa-Lyonnet D, Houdayer C, Gauthier-Villars M. 2007. Genotype-phenotype correlations in hereditary familial retinoblastoma. Hum Mutat 28:284-293. (Pubitemid 46309978)
24. Touliatou V, Fryssira H, Mavrou A, Kanavakis E, Kitsiou-Tzeli S. 2006. Clinical manifestations in 17 Greek patients with Goldenhar syndrome. Genet Couns 17:359-370. (Pubitemid 44639222)
25. Wang R, Martínez-Frías ML, Graham JM, Jr. 2002. Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence:A case-based and case-control approach. J Pediatr 141:611-617.
26. Wieser R, Fritz B, Ullmann R, Müller I, Galhuber M, Storlazzi CT, Ramaswamy A, Christiansen H, Shimizu N, Rehder H. 2005. Novel rearrangement of chromosome band 22q11.2 causing 22q11 microdeletion syndrome-like phenotype and rhabdoid tumor of the kidney. Hum Mutat 26:78-83. (Pubitemid 41040675)
27. Xu J, Fan YS, Siu VM. 2008. A child with features of Goldenhar syndrome and a novel 1.12 Mb deletion in 22q11.2 by cytogenetics and oligonucleotide array CGH: Is this a candidate region for the syndrome? Am J Med Genet Part A 146A:1886-1889.